Cell-type-specific genome editing with a microRNA-responsive CRISPR-Cas9 switch …………… Hirosawa M, Fujita Y, Parr CJC, Hayashi K, Kashida S, Hotta A, Woltjen K, Saito H. Nucleic Acids Res. 2017 May 19. PubMed 00
RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes …………… East-Seletsky A, O’Connell MR, Burstein D, Knott GJ, Doudna JA. Mol Cell. 2017 May 4;66(3):373-383.e3. PubMed 00
Replacing antibodies with modified DNA aptamers in vaccine potency assays …………… Trausch JJ, Shank-Retzlaff M, Verch T. Vaccine. 2017 Apr 19. pii: S0264-410X(17)30454-1. PubMed 00
Complementary oligonucleotides regulate induced fit ligand binding in duplexed aptamers …………… Munzar JD, Ng A, Corrado M, Juncker D. Chem Sci. 2017 Mar 1;8(3):2251-2256. PubMed 00